Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study

Total article views   Abstract views HTML views PDF downloads Totals
6,062 Dovepress* 4,127 686+ 1,224 4,813
PubMed Central* 0 1,249 247 1,249
Totals 4,127 1,935 1,471 6,062
*Since 6 December 2018
+Since July 2016

View citations on PubMed Central and Google Scholar